Akros Monthly Valuation
| MPAY Etf | USD 26.02 0.15 0.58% |
At this time, the entity appears to be fairly valued. Akros Monthly Payout shows a prevailing Real Value of $25.8 per share. The current price of the entity is $26.02. Our model approximates the value of Akros Monthly Payout from analyzing the entity fundamentals such as Profit Margin of (260.32) %, return on equity of -181.7, and Current Valuation of 1.25 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Akros Monthly's price fluctuation is very steady at this time. Calculation of the real value of Akros Monthly Payout is based on 3 months time horizon. Increasing Akros Monthly's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Akros Monthly is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akros Etf. However, Akros Monthly's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.02 | Real 25.8 | Hype 26.01 | Naive 26.21 |
The intrinsic value of Akros Monthly's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Akros Monthly's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Akros Monthly Payout helps investors to forecast how Akros etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akros Monthly more accurately as focusing exclusively on Akros Monthly's fundamentals will not take into account other important factors: Akros Monthly Total Value Analysis
Akros Monthly Payout is now forecasted to have valuation of 1.25 M with market capitalization of 158.56 K, debt of 1.11 M, and cash on hands of 23.87 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Akros Monthly fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.25 M | 158.56 K | 1.11 M | 23.87 K |
Akros Monthly Investor Information
Akros Monthly is is formed as Regulated Investment Company in the United States. ETF is managed and operated by The Bank of New York Mellon Corporation. The fund has 60 constituents across multiple sectors and instustries. The fund charges 0.75 percent management fee with a total expences of 0.84 percent of total asset. The fund maintains most of the assets in different exotic instruments. Based on the key measurements obtained from Akros Monthly's financial statements, Akros Monthly Payout is not in a good financial situation at the present time. It has a very high likelihood of going through financial trouble in January.Akros Monthly Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Akros Monthly has an asset utilization ratio of 18.46 percent. This suggests that the ETF is making $0.18 for each dollar of assets. An increasing asset utilization means that Akros Monthly Payout is more efficient with each dollar of assets it utilizes for everyday operations.Akros Monthly Ownership Allocation
Akros Monthly Payout retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Akros Monthly Profitability Analysis
The company reported the previous year's revenue of 407.98 K. Net Loss for the year was (1.06 M) with profit before overhead, payroll, taxes, and interest of 438.28 K.About Akros Monthly Valuation
Our relative valuation model uses a comparative analysis of Akros Monthly. We calculate exposure to Akros Monthly's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Akros Monthly's related companies. When determining whether Akros Monthly Payout offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akros Monthly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akros Monthly Payout Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Akros Monthly Payout Etf:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Akros Monthly Payout. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
The market value of Akros Monthly Payout is measured differently than its book value, which is the value of Akros that is recorded on the company's balance sheet. Investors also form their own opinion of Akros Monthly's value that differs from its market value or its book value, called intrinsic value, which is Akros Monthly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akros Monthly's market value can be influenced by many factors that don't directly affect Akros Monthly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akros Monthly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akros Monthly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akros Monthly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.